Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check2 days agoChange DetectedThe clinical-trial record for the Phase 3 avacopan study is displayed, with detailed study information and supporting documents.SummaryDifference100%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA notice about NIH’s website transition and terminology appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedA 403 Forbidden page is now shown, with a basic header and Home link, replacing the prior detailed study content and documents with an access-restricted screen.SummaryDifference18%

- Check58 days agoChange DetectedThe page displays a new revision tag: Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates the page has been updated to reflect a newer version.SummaryDifference0.0%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.